Term ends Apr 28, 2037 · High confidence
20-year base term ends Jan 9, 2038
Held by Biomunex Pharmaceuticals
Filed Jul 9, 2019 as application 16/476,624 · Granted Apr 16, 2024
Base term plus 489 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2018
2038
Clock starts
Jan 9, 2018
Jan 9, 2018
Term ends
Apr 28, 2037
Apr 28, 2037
Granted
Apr 16, 2024
Apr 16, 2024
base term
after the term ends
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
489
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,505,616, US 11,560,437, US 12,054,550.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 489 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 9, 2018, when application PCT/EP2018/050481, the earliest non-provisional in its chain, was filed (this one was filed Jul 9, 2019) | Jan 9, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +489 days, USPTO patent term adjustment record | May 13, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,505,616, US 11,560,437, US 12,054,550) | capped to Apr 28, 2037 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 28, 2037 | High confidence |
This family
| US 11,958,913 | this patent Apr 2037 | Apr 2037 |
| Application 18/589,695 | Pending not computed | not computed |
2 of 3 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 17, 2019 Reel 50747, frame 774 | Zhukovsky, Eugene; Leger, Olivier | Biomunex Pharmaceuticals | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2037
Term ends Apr 28, 2037. Maintenance fees still fall due before then
Note
The 489 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,505,616, US 11,560,437, US 12,054,550.
Citations
4
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.